Current research models do not properly mimic biological processes in a living organism. FinnAdvance has developed novel designs, and methods to create biomimetic chips that simulate live tissues. Together with their European partners they have received funding for the H2020-MSCA-ITN project called V.A. Cure to help apply disease models from EU countries; expanding the portfolio of diseases on FinnAdvance’s chips.